Mafalda Oliveira
MD PhD
Medical Oncologist
👥Biography 个人简介
Mafalda Oliveira has contributed to HR-positive breast cancer research, including work on endocrine resistance mechanisms particularly ESR1 mutations that arise after aromatase inhibitor treatment. Her research on novel endocrine agents targeting ESR1-mutant breast cancer (including elacestrant, a selective estrogen receptor degrader/SERD) and on combinations overcoming CDK4/6 inhibitor resistance addresses critical challenges in advanced HR+ breast cancer.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-03-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Mafalda Oliveira 的研究动态
Follow Mafalda Oliveira's research updates
留下邮箱，当我们发布与 Mafalda Oliveira（Vall d'Hebron University Hospital）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment